AI assistant
Sending…
CORCEPT THERAPEUTICS INC — Director's Dealing 2016
Nov 15, 2016
30681_dirs_2016-11-14_267e2bc7-c0c8-4544-a97c-d5e4bb3534a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-11-11
Reporting Person: MAHONEY DAVID L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-11 | Common Stock | M | 30000 | $2.70 | Acquired | 1199320 | Indirect |
| 2016-11-11 | Common Stock | S | 30000 | $9.35 | Disposed | 1169320 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-11 | Stock Option (Right to Buy) | $2.70 | M | 30000 | Disposed | 2017-12-19 | Common Stock (30000) | Direct |
Footnotes
F1: Fully exercisable.
More from CORCEPT THERAPEUTICS INC
Legal Proceedings Report
2026
Jun 3
Share Issue/Capital Change
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24